help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/endo-96-1-107
Endocrinology Vol. 96, No. 1 107-118
Copyright © 1975 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KRULICH, L.
Right arrow Articles by ASCHENBRENNER, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KRULICH, L.
Right arrow Articles by ASCHENBRENNER, J. E.

Mechanism of the Effects of Hypothalamic Deafferentation on Prolactin Secretion in the Rat1

L. KRULICH, E. HEFCO2 and J. E. ASCHENBRENNER3

Department of Physiology, The University of Texas Health Science Center at Dallas, Southxoestern Medical School Dallas, Texas 75235

Abstract

Male rats with complete hypothalamic deafferentation had consistently lower serum prolactin concentrations than controls when the blood samples were obtained under ether anesthesia. However, when rats were decapitated, both groups had similar low prolactin levels. Posterolateral deafferentation was as effective as complete deafferentation in preventing the stress-induced prolactin release, whereas anterior frontal deafferentation had only a small effect. L-Dopa (100 mg/kg body wt, ip) decreased prolactin titers in both control and deafferented animals, whereas reserpine (1 mg/kg body wt, ip) had the opposite effect. Since both drugs inhibited prolactin release from pituitaries in vitro, the decrease of prolactin levels following L-dopa in vivo might have been caused not only by stimulation of PIF release but also at least partly by the direct effect of the drug on the pituitary. However, the increase of serum prolactin following reserpine was in all probability caused by inhibition of PIF secretion. Electrolytic lesions in the median eminence of deafferented rats caused an elevation of serum prolactin, which was more marked in female than in male rats. On the contrary, deafferentation in the females affected prolactin levels less than in males. It is concluded that hypothalamic deafferentation prevents ether-induced release of prolactin and that the "low" levels of the deafferented animals are probably due to a tonic release of prolactin-inhibiting factor (PIF) from the isolated island. It is though that this continuous release of PIF might be maintained by persisting autonomous activity of the adrenergic, presumably dopaminergic, neurons contained in the isolated island. (Endocrinology 96: 107, 1975)

Footnotes

1 Supported by grants from NIH (AM 10073 and HD 05151), the Ford Foundation and the Texas Population Research Institute.

2 Present address: Centrul de Cercetari Biologice, Iasi, Romania.

3 Present address: Department of Physiology, North Texas State University, Denton, Texas.

Received March 21, 1974.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1975 by The Endocrine Society